CIR CONFIRMATION GRANTED TO PHARMACELS
Pharmacelsus (member of GBA Group Pharma) is proud to announce that again we have been rewarded with the CIR confirmation for research and innovation. We are very honored that our scientific research has been proofed and recognized with this certificate. This authorization granted by the French Ministry of Higher Education, Research and Development is valid for the years 2021, 2022 and 2023 and was first granted to Pharmacelsus in 2015.